Voltar
Revisão Revisado por pares
BIBTEX RIS

Antibody–drug conjugate as targeted therapeutics against hepatocellular carcinoma: preclinical studies and clinical relevance

2021; Springer Science+Business Media; Volume: 24; Issue: 3 Linguagem: Inglês

10.1007/s12094-021-02707-5

ISSN

1699-3055

Autores

Meena Murali, Ayana R. Kumar, Bhagyalakshmi Nair, K Pavithran, Aswathy R. Devan, Goriparthi Pradeep, Lekshmi R. Nath,

Tópico(s)

PI3K/AKT/mTOR signaling in cancer

Referência(s)